Clinical Trial Update: The Synergism Or Long Duration (SOLD) Study [Phase 3]

View source ↗

Summary

The SOLD study, a Phase 3 clinical trial sponsored by the Finnish Breast Cancer Group, has completed. The trial focused on breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Finnish Breast Cancer Group | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED